All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

34

Reset

34 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • CagrilintidePhase 320 trials

    Novo Nordisk · Obesity, Overweight, Type 2 Diabetes

  • RetatrutideLY3437943Phase 316 trials

    Eli Lilly · Obesity, Overweight, Type 2 Diabetes

  • HRS-7535Phase 310 trials

    Shandong Suncadia Medicine Co., Ltd. · Type 2 Diabetes, Chronic Kidney Disease, Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity

  • UBT251Phase 310 trials

    The United Bio-Technology (Hengqin) Co., Ltd. · Obesity, Obesity &Amp; Overweight, Diabetes Mellitus, Type 2

  • ElecoglipronPhase 39 trials

    AstraZeneca · Type 2 Diabetes Mellitus, Obesity, Overweight

  • ZenagamtidePhase 39 trials

    Novo Nordisk · Obesity, Overweight, Type 2 Diabetes

  • CM336group, QiShen YiQi Dripping Pills 3 bagsPhase 37 trials

    Keymed Biosciences Co.Ltd · Multiple Myeloma (MM), Primary Light-Chain Amyloidosis, Primary Immune Thrombocytopenia

  • AND017Phase 36 trials

    Kind Pharmaceuticals LLC · Anemia Due to Chronic Kidney Disease, β -Thalassemia, Cancer-Related Anemia

  • FUB523zigakibart, BION-1301Phase 36 trials

    Novartis · IgA Nephropathy, Immunoglobulin A Nephropathy, IgA Nephropathy (IgAN)

  • lorundrostatPhase 35 trials

    Mineralys Therapeutics Inc. · Hypertension, Obstructive Sleep Apnea, Chronic Kidney Disease

  • VicadrostatBI 690517Phase 35 trials

    Boehringer Ingelheim · Heart Failure, Diabetes Mellitus, Type 2, Hypertension

  • BI 764198ApecotrepPhase 33 trials

    Boehringer Ingelheim · Focal Segmental Glomerulosclerosis, Proteinuric Kidney Diseases, Kidney Disease, Chronic

  • ESAErythropoiesis-Stimulating AgentPhase 33 trials

    Kind Pharmaceuticals LLC · Anemia Due to Chronic Kidney Disease, Anemia of Chronic Kidney Disease

  • HRS-1780Phase 33 trials

    Shandong Suncadia Medicine Co., Ltd. · Chronic Kidney Disease, Uncontrolled or Resistant Hypertension, Primary Aldosteronism

  • MT1013Phase 33 trials

    Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis, Secondary Hyperparathyroidism, Chronic Kidney Disease

  • PacibekitugTOUR006, PAC001Phase 33 trials

    Tourmaline Bio, Inc., a Novartis Company · Myocardial Infarction, Thyroid Eye Disease, Chronic Kidney Diseases

  • PLS240upacicalcetPhase 33 trials

    Pathalys Pharma · Secondary Hyperparathyroidism, Chronic Kidney Disease (CKD), End-stage Kidney Disease (ESKD)

  • ABP-671Phase 32 trials

    Atom Therapeutics Co., Ltd · Chronic Kidney Disease, Gout

  • AP301Solnatide for reconstitution for forPhase 32 trials

    Alebund Pharmaceuticals · Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, ESRD (End-Stage Renal Disease)

  • ClazakizumabLY5724886, CSL300Phase 32 trials

    Eli Lilly · Atherosclerosis, Cardiovascular Disease, Obesity

  • QRX-3EseronatePhase 32 trials

    Ebima Clifford Okundaye · Chronic Kidney Diseases, Acute Kidney Injury, Kidney Failure

  • rilparencelRenal Autologous Cell Therapy, REACTPhase 32 trials

    Prokidney · Type 2 Diabetes Mellitus, Chronic Kidney Diseases, Type 1 Diabetes Mellitus

  • RoxadustatFG-4592, ASP1517Phase 32 trials

    Astellas · Chronic Kidney Disease, Renal Anemia, Myelodysplastic Syndromes

  • SAL0120Phase 32 trials

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Chronic Kidney Disease, Uncontrolled Hypertension, Resistant Hypertension

  • SHR6508Phase 32 trials

    Shanghai Hengrui Pharmaceutical Co., Ltd. · Secondary Hyperparathyroidism, Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis

  • BCD-131pegdarbepoetin betaPhase 31 trial

    Biocad · Anemia, Chronic Kidney Disease, Chronic Kidney Disease Patients on Hemodialysis

  • NNC0519-0130Phase 23 trials

    Novo Nordisk · Chronic Kidney Disease, Diabetes Mellitus, Type 2, Obesity

  • SAL0140Phase 23 trials

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Primary Aldosteronism, Chronic Kidney Disease, Uncontrolled Hypertension

  • REGN5459Vonsetamig, BCMAxCD3Phase 22 trials

    Regeneron · Chronic Kidney Disease (CKD), Relapsed Multiple Myeloma, Refractory Multiple Myeloma

  • AION-301Phase 21 trial

    AION Healthspan, Inc. · Chronic Kidney Disease Stage 3

  • AP306Phase 21 trial

    R1 Therapeutics · Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis, End Stage Renal Disease on Dialysis

  • BAY3283142Phase 21 trial

    Bayer · Chronic Kidney Disease

  • HS-10390Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Kidney Disease

  • IGT-303Phase 21 trial

    Ingenia Therapeutics INC · Healthy Volunteers, Chronic Kidney Disease

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.